Where does Ontario Institute for Cancer Research (OICR) rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ontario Institute for Cancer Research (OICR) ranks #20,199 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ontario Institute for Cancer Research (OICR) hold?

Ontario Institute for Cancer Research (OICR) holds 14 US utility patents granted between 2020 and 2025, spanning 14 technology areas.

What is Ontario Institute for Cancer Research (OICR)'s Innovation Score?

Ontario Institute for Cancer Research (OICR) has an Innovation Score of 47.4 out of 100 (top 19% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Ontario Institute for Cancer Research (OICR) focus on?

Ontario Institute for Cancer Research (OICR)'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 9 patents, ranking #2,395 of 7,163 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

Is Ontario Institute for Cancer Research (OICR)'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Ontario Institute for Cancer Research (OICR).

What does claim depth mean for Ontario Institute for Cancer Research (OICR)'s patents?

Ontario Institute for Cancer Research (OICR)'s patents average 16.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ontario Institute for Cancer Research (OICR)

Q: How is the Ontario Institute for Cancer Research (OICR) patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 14 granted patents across 14 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ontario ranks #20,199 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 14 technology areas.

#20,199
of 49,997 US assignees by volume: Top 19%
by Innovation Score (47.4/100): 16.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R20199 · Foreign Corporation #20,199 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 14 grants
MID-PACK #20,199/49,997
PHOTO-FINISH OmniEarth
CPC-FOCUS A61K · 14 areas
INNOV-PAR 47.4/100
CLAIMS-RICH 16.4 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: OmniEarth, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ontario’s 47.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (20%) Velocity 15.0 pts (32%) Breadth 13.2 pts (28%) Claim depth 9.9 pts (21%)

Qualcomm Incorporated · highest

85
Everseen · near

47
IMBA—INSTITUT FÜR… · near

47
National University… · near

47
Ontario Institute… · this assignee

47
UMC Utrecht Holding… · near

47
3D Lighting… · lowest

7

What this shows Ontario's Innovation Score is 47.4/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ontario?

Each dot is one of Ontario’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ontario’s own 16.4 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ontario vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ontario's grants concentrate

Ontario Institute for Cancer Research (OICR) is a focused PatentsView assignee: 14 CPC subclasses with 64.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (6 grants) versus a trough of 2 in 2020. By volume, Ontario sits between OmniEarth, Inc. and Ossianix, Inc..

Ontario's three-year grant acceleration

Ontario Institute for Cancer Research (OICR) shows 9 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Omniearth

14
On Point Ball Mar…

14
Oncoceutics

14
One Drop Biosensor

14
Operative Medical…

14
Orora Packaging S…

14
Oskar Frech + KG

14
Ossianix

14
Ontario Institute… ◀

14

What this shows Ontario holds 14 patents at rank #20,205, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ontario

By rank, the assignees closest to #20,205 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Ontario's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ontario, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Ontario ranks #2,395 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (47 here).

IMBA—INSTITUT FÜR Molekulare Biotechnologie GMBH 47 Everseen Limited 47 National University Corporation Nara Institute OF Science AND Technology 47 UMC Utrecht Holding B.V. 47

Ontario's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Ontario Institute for Cancer Research (OICR) patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	14.3%
2021	2	14.3%
2022	6	42.9%
2023	3	21.4%
2025partial year	1	7.1%

Which technologies does Ontario Institute for Cancer Research (OICR) patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 7

C07D - Heterocyclic Compounds 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

C07K - Peptides 2

A01P - Biocidal, Pest Repellant, Pest Attractant OR Plant Growth Regulatory Activity OF Chemical Compounds OR Preparations 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C07C - Acyclic OR Carbocyclic Compounds 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ontario Institute for Cancer Research (OICR)'s patent record in context - here's where to go next.

Ontario Institute for Cancer Research (OICR)'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 64.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #20,199 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ontario Institute for Cancer Research (OICR) against OmniEarth, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.